CRSP is trading at $54.77, up 5.3% versus the comparison close of $52.02 during regular trading. This is a price-movement alert; no separate company-specific catalyst was searched for this follow-up.
🟢 Crispr Therapeutics AG extends move to 5.3% up
Crispr Therapeutics AG
Related News
CRSP
CRISPR Therapeutics reports promising interim CTX112 results in autoimmune trial
CRSP
🔴 Crispr Therapeutics falls 4.1% — Biotech Sector Declines Amid Broad Market Rotation
CRSP
🟢 Crispr Therapeutics rises 4.3% — Biotech Sector Rallies on Positive Clinical Data and Regulatory News
CRSP
🟢 Crispr Therapeutics rises 5.3% — Biotech Sector Rallies on Strong IPO Debuts and M&A Activity
CRSP